Furthermore, IL-15’s role in combination with other NK-based therapies, such as CAR NK cells and membrane-bound IL-15 (mbIL-15), presents an exciting frontier in the treatment of hematologic malignancies. The gene discussed is IL15; the disease is hematologic disorder.